AKORN INC
10-K/A, 2000-04-06
PHARMACEUTICAL PREPARATIONS
Previous: AEROFLEX INC, S-3, 2000-04-06
Next: AMERICAN INTERNATIONAL GROUP INC, DEF 14A, 2000-04-06



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549
- --------------------------------------------------------------------------------
                                   FORM 10-K/A

            [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934

                      FOR THE YEAR ENDED DECEMBER 31, 1999

          [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934

                         Commission File Number: 0-13976

                                   AKORN, INC.
                (Name of registrant as specified in its charter)

           LOUISIANA                                  72-0717400
(State or other jurisdiction of              (IRS Employer Identification No.)
incorporation or organization)

               2500 Millbrook Drive, Buffalo Grove, Illinois 60089
              (Address of principal executive offices and zip code)

                  Registrant's telephone number: (847) 279-6100

         SECURITIES REGISTERED UNDER SECTION 12(b) OF THE EXCHANGE ACT:
                                      None

         SECURITIES REGISTERED UNDER SECTION 12(g) OF THE EXCHANGE ACT:
                           Common Stock, No Par Value
                                (Title of Class)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12
months (or for such shorter period that the Registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days. Yes  X    No
         -----    -----

Indicate by check mark if disclosure of delinquent filers in response to Item
405 of Regulation S-K is not contained in this form, and will not be contained,
to the best of Registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. [ ]

The aggregate market value of the voting stock held by nonaffiliates (affiliates
being, for these purposes only, directors, executive officers and holders of
more than 5% of the Issuer's common stock) of the Issuer as of March 15, 2000
was approximately $124,200,000.

The number of shares of the Issuer's common stock, no par value per share,
outstanding as of March 15, 2000 was 18,968,802.

                       DOCUMENTS INCORPORATED BY REFERENCE

Part III of this Annual Report on Form 10-K incorporates by reference portions
of the Registrant's definitive proxy statement for its 2000 Annual Meeting of
Shareholders filed with the Securities and Exchange Commission on March 28,
2000.


<PAGE>   2


Akorn, Inc. hereby amends Item 12, Part III of its Annual Report on Form 10-K
for the fiscal year ended December 31, 1999 (which was incorporated by reference
to the definitive proxy statement for its 2000 Annual Meeting of Shareholders
filed on March 28, 2000) as follows:

The information regarding Doyle S. Gaw and Directors and officers as a group (5
persons) in the table labeled "Beneficial Owners" shall be as set forth below:

Beneficial Owner             Shares Beneficially Owned         Percent of Class
- ----------------             -------------------------         ----------------

Doyle S. Gaw                          105,360 (2)                    0.52%
Directors and officers as a
  group (5 persons)                 5,707,824 (6)                   28.39%





<PAGE>   3

                                   SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

                                            AKORN, INC.


                                            By: /s/ Floyd Benjamin
                                               --------------------------------
                                                   Floyd Benjamin
                                                   Chief Executive Officer

Date:  April 6, 2000

Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed below by the following persons on behalf of the Registrant, and
in the capacities and on the dates indicated.
<TABLE>
<CAPTION>

Signature                            Title                                  Date
- ---------                            -----                                  ----

<S>                                  <C>                                    <C>
/s/ Floyd Benjamin                   Chief Executive Officer and Director   April 6, 2000
- ---------------------------
Floyd Benjamin                       (Principal Executive Officer)

/s/ Rita J. McConville               Chief Financial Officer                April 6, 2000
- ---------------------------
Rita J. McConville                   (Principal Financial Officer and
                                     Principal Accounting Officer)

/s/  John N. Kapoor, Ph.D.           Director                               April 6, 2000
- ---------------------------
John N. Kapoor, Ph.D.

/s/ Daniel E. Bruhl, M.D.            Director                               April 6, 2000
- ---------------------------
Daniel E. Bruhl, M.D.

/s/ Doyle S. Gaw                     Director                               April 6, 2000
- ---------------------------
Doyle S. Gaw
</TABLE>







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission